Type of Care:
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Residential/24-hour residential Short-term residential
Opioid Medications used in Treatment:
Naltrexone used in Treatment
External Opioid Medications Source:
Other contracted prescribing entity
Type of Alcohol Use Disorder Treatment:
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment:
In-network prescribing entity Other contracted prescribing entity
Type of Opioid Treatment:
Accepts clients using MAT but prescribed elsewhere Lofexidine or Clonidine detoxification
Pharmacotherapies:
Acamprosate (Campral®) Disulfiram Naltrexone (oral) Clonidine Medication for mental disorders Nicotine replacement
Treatment Approaches:
Brief intervention Cognitive behavioral therapy Motivational interviewing Relapse prevention Substance use disorder counseling 12-step facilitation
Facility Operation (e.g., Private, Public):
Private non-profit organization
License/Certification/Accreditation:
State Substance use treatment agency
Assessment/Pre-treatment:
Comprehensive substance use assessment Screening for substance use
Testing:
Drug or alcohol urine screening
Transitional Services:
Discharge Planning
Recovery Support Services:
Self-help groups Recovery coach Mentoring/peer support
Education and Counseling Services:
Substance use disorder education Individual counseling Group counseling
Facility Smoking Policy :
Smoking permitted in designated area
Age Groups Accepted:
Young Adults Adults
Language Services:
Spanish Sign language services for the deaf and hard of hearing
Facility Vaping Policy:
Vaping permitted in designated area
Ancillary Services:
Case management service